The selected newsroom has been added to your list of favorites. Go to My Favorites

Our News on Newswise

Newswise: IMG_0199.jpeg

Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2

A new study led by scientists at La Jolla Institute for Immunology (LJI) shows that memory helper T cells that recognize common cold coronaviruses also recognize matching sites on SARS-CoV-2, the virus that causes COVID-19.
4-Aug-2020 10:00 AM EDT Add to Favorites

Newswise: TCR-peptide-MHC.png

T cells can shift from helping to harming in atherosclerosis

At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place. In a new study, LJI scientists show that certain T lymphocytes, a type of white blood cell, that start out trying...
22-Jul-2020 8:05 PM EDT Add to Favorites

Newswise: Bloodvesselsmall.jpg

Researchers track down metabolic enzyme that protects against inflammation

A new study from scientists at the La Jolla Institute for Immunology (LJI) shows that a previously poorly understood enzyme actually inhibits inflammation in blood vessels. The research offers a potential path to treating DADA2, an inflammatory...
17-Jul-2020 2:20 PM EDT Add to Favorites

Newswise: Virus_distributionweb.png

From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make...
2-Jul-2020 12:05 PM EDT Add to Favorites

Even in the worst COVID-19 cases, the body launches immune cells to fight back

SHAREInternational collaboration provides important piece of COVID-19 puzzleLA JOLLA—A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19...
29-Jun-2020 12:25 PM EDT Add to Favorites

Newswise: Figforpressrelease.png

LJI Scientists Investigate a Powerful Protein Behind Antibody Development

Scientists at the La Jolla Institute for Immunology (LJI) have discovered a potential new way to better fight a range of infectious diseases, cancers and even autoimmune diseases. The new study, published recently in Nature Immunology, shows how a...
17-Jun-2020 4:35 PM EDT Add to Favorites

Newswise: housedustmite.jpeg

LJI scientists uncover immune cells that may lower airway allergy and asthma risk

In a new Science Immunology study, published on June 12, 2020, scientists at La Jolla Institute for Immunology (LJI) offer a clue to why non-allergic people don’t have a strong reaction to house dust mites. They’ve uncovered a previously unknown...
10-Jun-2020 5:05 PM EDT Add to Favorites

Newswise: JEV_Zika_range.png

Fighting Mosquito-Borne Viruses Requires a Precise Balance of Immune Cells

In a new study, published June 5, 2020, in the Journal of Experimental Medicine, scientists at La Jolla Institute for Immunology (LJI) shows that antibodies against JEV are “cross-reactive” and can also recognize Zika virus. Unfortunately, these...
4-Jun-2020 2:35 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: EricaSaphire-139_p.jpg

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: 2018Dr.MatthiasvonHerrath.jpg

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Contacts

Gina Kirchweger
Chief Communications Officer
allergy immunology

gina@lji.org

858-752-6640

Jenna Hambrick
Digital Strategist

jhambrick@lji.org

858.752.6645

Madeline McCurry-Schmidt
Science Writer

madeline@lji.org

619-438-2382

Twitter

close
0.45803